Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial) is not associated with mutations conferring viral resistance.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples